Sherilyn A Tuazon

4PUBLICATIONS
11CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 14, 2021
Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphoma.

Victor A Chow, Ryan D Cassaday, Theodore A Gooley

|Feb 10, 2021
A clinical perspective on plasma cell leukemia; current status and future directions.

Sherilyn A Tuazon, Leona A Holmberg, Omar Nadeem

|Jul 26, 2020
90Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma.

Sherilyn A Tuazon, Brenda M Sandmaier, Theodore A Gooley

|Feb 08, 2019
Factors affecting lymphocyte collection efficiency for the manufacture of chimeric antigen receptor T cells in adults with B-cell malignancies.

Sherilyn A Tuazon, Ang Li, Theodore Gooley

Pageof 1

Frequent Collaborators

1 joint publications

Pamela S Becker

1 joint publications

Brian G Till

1 joint publications

John M Pagel

1 joint publications

Damian J Green